Researchers are hopeful for the next round of the study since tofacitinib shows potential in those with scleroderma
Editor It affects 100,000 persons in the US alone. Scleroderma, also known as systemic sclerosis, is a group of…
It affects 100,000 persons in the US alone. Scleroderma, also known as systemic sclerosis, is a group of…
